Protections against the Risk of Airborne SARS-CoV-2 Infection

QR Code

Protections against the Risk of Airborne SARS-CoV-2 Infection

Enregistré dans:

Détails bibliographiques
Auteur principal:	Clement J. McDonald
Format:	article
Langue:	EN
Publié:	American Society for Microbiology 2020
Sujets:	COVID-19 HEPA filters N95 respirator route of infection SARS-CoV-2 airborne microorganisms Microbiology QR1-502
Accès en ligne:	https://doaj.org/article/ced2baa618164c79b1d7db8e7f20c44e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The Impact of Large Mobile Air Purifiers on Aerosol Concentration in Classrooms and the Reduction of Airborne Transmission of SARS-CoV-2
par: Finn F. Duill, et autres
Publié: (2021)

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2
par: Hiroshi Ueki, et autres
Publié: (2020)

The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation
par: A. Mikszewski, et autres
Publié: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
par: Ravi Kant, et autres
Publié: (2021)

Can a Nasal/Oral/Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis
par: Fuentes,Edgardo, et autres
Publié: (2020)

Microwave-Generated Steam Decontamination of N95 Respirators Utilizing Universally Accessible Materials
par: Katelyn E. Zulauf, et autres
Publié: (2020)

Evaluation of Residual Infectivity after SARS-CoV-2 Aerosol Transmission in a Controlled Laboratory Setting
par: Luisa Zupin, et autres
Publié: (2021)

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
par: Haijun Tang, et autres
Publié: (2021)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
par: Haijun Tang, et autres
Publié: (2021)

Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
par: Lili Zhao, et autres
Publié: (2021)

La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
par: Morales-Espinosa,Rolando
Publié: (2020)

Assessing SARS-CoV-2 Vertical Transmission and Neonatal Complications
par: Cosmin Citu, et autres
Publié: (2021)

Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning
par: Shira Doron, et autres
Publié: (2021)

Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
par: Brandon J. Beddingfield, et autres
Publié: (2021)

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
par: Taweewun Hunsawong, et autres
Publié: (2021)

Pandemia SARS-CoV-2 y embarazo en el Hospital el Pino: un estudio descriptivo
par: Morales M.,Nereida, et autres
Publié: (2020)

Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic?
par: Arturo Casadevall, et autres
Publié: (2021)

SARS-CoV-2 Prevalence in Laparoscopic Surgery Filters. Analysis in Patients with Negative Oropharyngeal RT-qPCR in a Pandemic Context: A Cross-Sectional Study
par: Antoni Llueca, et autres
Publié: (2021)

Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency
par: Karolina Pieniawska-Śmiech, et autres
Publié: (2021)

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19
par: Tarlan Mamedov, et autres
Publié: (2021)

Telehealth in the times of SARS-CoV-2 infection for the otolaryngologist
par: Victoria W. Huang, et autres
Publié: (2020)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
par: Christopher A. Beaudoin, et autres
Publié: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
par: Lea Hsu, et autres
Publié: (2021)

The effect of eye protection on SARS-CoV-2 transmission: a systematic review
par: Oyungerel Byambasuren, et autres
Publié: (2021)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
par: Ángel Estella, et autres
Publié: (2021)

Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
par: Dharmendra Kumar Yadav, et autres
Publié: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
par: Xiaodong Tian, et autres
Publié: (2021)

SARS-CoV-2 en atención odontológica: vías de transmisión y sus consideraciones en la práctica clínica
par: Cruzat Villalobos,Gilena, et autres
Publié: (2020)

An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate
par: Sorin Barac, et autres
Publié: (2021)

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
par: Kun Li, et autres
Publié: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
par: Carlos del Fresno, et autres
Publié: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
par: Shaikh Terkis Islam Pavel, et autres
Publié: (2021)

In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2
par: Justine Defêche, et autres
Publié: (2021)

SARS-CoV-2 and Public Transport in Italy
par: Giuseppina Caggiano, et autres
Publié: (2021)

SARS-CoV-2 Modelo de Inoculación en la Cavidad Oral. Revisión de la Literatura
par: Villanueva-Sánchez,Francisco Germán, et autres
Publié: (2020)

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
par: Jennifer K. DeMarco, et autres
Publié: (2021)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
par: Doris Urlaub, et autres
Publié: (2021)

Decontamination Methods of N95 Respirators Contaminated with SARS-CoV-2
par: Thirumaaran Gopalan, et autres
Publié: (2021)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
par: Olivier Bylicki, et autres
Publié: (2021)

Mouthwashes and Nasal Sprays as a Way to Prevent the Spread of SARS-CoV-2
par: Santos-López,Matías, et autres
Publié: (2020)